Jemperli Interactions
There are 605 drugs known to interact with Jemperli (dostarlimab), along with 2 disease interactions. Of the total drug interactions, 3 are major, and 602 are moderate.
- View all 605 medications that may interact with Jemperli
- View Jemperli disease interactions (2)
Most frequently checked interactions
View interaction reports for Jemperli (dostarlimab) and the medicines listed below.
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Actemra (tocilizumab)
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Advair HFA (fluticasone / salmeterol)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Alhemo (concizumab)
- alprazolam
- Altuviiio (antihemophilic factor)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- amitriptyline
- Amondys 45 (casimersen)
- Andembry (garadacimab)
- Cymbalta (duloxetine)
- Dupixent (dupilumab)
- Eliquis (apixaban)
- Evenity (romosozumab)
- hydroxychloroquine
- Keytruda (pembrolizumab)
- methocarbamol
- omeprazole
- prednisone
- Repatha (evolocumab)
- Trulicity (dulaglutide)
Jemperli disease interactions
There are 2 disease interactions with Jemperli (dostarlimab) which include:
Report options
QR code containing a link to this page
More about Jemperli (dostarlimab)
- Jemperli consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
